These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

287 related articles for article (PubMed ID: 9083154)

  • 1. Altered retinoblastoma protein expression in nonsmall cell lung cancer: its synergistic effects with altered ras and p53 protein status on prognosis.
    Dosaka-Akita H; Hu SX; Fujino M; Harada M; Kinoshita I; Xu HJ; Kuzumaki N; Kawakami Y; Benedict WF
    Cancer; 1997 Apr; 79(7):1329-37. PubMed ID: 9083154
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Altered retinoblastoma and p53 protein status in non-small cell carcinoma of the lung: potential synergistic effects on prognosis.
    Xu HJ; Cagle PT; Hu SX; Li J; Benedict WF
    Clin Cancer Res; 1996 Jul; 2(7):1169-76. PubMed ID: 9816284
    [TBL] [Abstract][Full Text] [Related]  

  • 3. p53, bcl-2 and retinoblastoma proteins as long-term prognostic markers in localized carcinoma of the prostate.
    Theodorescu D; Broder SR; Boyd JC; Mills SE; Frierson HF
    J Urol; 1997 Jul; 158(1):131-7. PubMed ID: 9186339
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Prognostic significance of cyclin D1 and retinoblastoma expression in combination with p53 abnormalities in primary, resected non-small cell lung cancers.
    Nishio M; Koshikawa T; Yatabe Y; Kuroishi T; Suyama M; Nagatake M; Sugiura T; Ariyoshi Y; Mitsudomi T; Takahashi T
    Clin Cancer Res; 1997 Jul; 3(7):1051-8. PubMed ID: 9815783
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Association of immunoreactive hepatocyte growth factor with poor survival in resectable non-small cell lung cancer.
    Siegfried JM; Weissfeld LA; Singh-Kaw P; Weyant RJ; Testa JR; Landreneau RJ
    Cancer Res; 1997 Feb; 57(3):433-9. PubMed ID: 9012470
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Protein expression of p53, p21WAF1, and Rb as prognostic indicators in patients with surgically treated hepatocellular carcinoma.
    Naka T; Toyota N; Kaneko T; Kaibara N
    Anticancer Res; 1998; 18(1B):555-64. PubMed ID: 9568177
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Mutations in exon 7 and 8 of p53 as poor prognostic factors in patients with non-small cell lung cancer.
    Huang C; Taki T; Adachi M; Konishi T; Higashiyama M; Miyake M
    Oncogene; 1998 May; 16(19):2469-77. PubMed ID: 9627113
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Altered p16INK4 and retinoblastoma protein status in non-small cell lung cancer: potential synergistic effect with altered p53 protein on proliferative activity.
    Kinoshita I; Dosaka-Akita H; Mishina T; Akie K; Nishi M; Hiroumi H; Hommura F; Kawakami Y
    Cancer Res; 1996 Dec; 56(24):5557-62. PubMed ID: 8971152
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Prognostic value of nuclear DNA content and expression of the ras oncogene product in lung cancer.
    Miyamoto H; Harada M; Isobe H; Akita HD; Haneda H; Yamaguchi E; Kuzumaki N; Kawakami Y
    Cancer Res; 1991 Dec; 51(23 Pt 1):6346-50. PubMed ID: 1657384
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Prognostic significance of p53 and ras p21 expression in nonsmall cell lung cancer.
    Fujino M; Dosaka-Akita H; Harada M; Hiroumi H; Kinoshita I; Akie K; Kawakami Y
    Cancer; 1995 Dec; 76(12):2457-63. PubMed ID: 8625071
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Altered retinoblastoma protein expression and prognosis in early-stage non-small-cell lung carcinoma.
    Xu HJ; Quinlan DC; Davidson AG; Hu SX; Summers CL; Li J; Benedict WF
    J Natl Cancer Inst; 1994 May; 86(9):695-9. PubMed ID: 8158700
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Clinicopathological study on primary lung cancer--immunohistochemical expression of p53 suppressor gene and bcl-2 oncogene in relation to prognosis].
    Irie K; Ishida H; Furukawa T; Koyanagi K; Miyamoto Y
    Rinsho Byori; 1996 Jan; 44(1):32-41. PubMed ID: 8691638
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Rb and p16INK4a expression in resected non-small cell lung tumors.
    Kratzke RA; Greatens TM; Rubins JB; Maddaus MA; Niewoehner DE; Niehans GA; Geradts J
    Cancer Res; 1996 Aug; 56(15):3415-20. PubMed ID: 8758904
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Inactivation of the retinoblastoma susceptibility gene in non-small-cell lung cancer. The Lung Cancer Study Group.
    Reissmann PT; Koga H; Takahashi R; Figlin RA; Holmes EC; Piantadosi S; Cordon-Cardo C; Slamon DJ
    Oncogene; 1993 Jul; 8(7):1913-9. PubMed ID: 8390038
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Correlation of KAI1/CD82 gene expression with good prognosis in patients with non-small cell lung cancer.
    Adachi M; Taki T; Ieki Y; Huang CL; Higashiyama M; Miyake M
    Cancer Res; 1996 Apr; 56(8):1751-5. PubMed ID: 8620488
    [TBL] [Abstract][Full Text] [Related]  

  • 16. A prognostic model of recurrence and death in stage I non-small cell lung cancer utilizing presentation, histopathology, and oncoprotein expression.
    Harpole DH; Herndon JE; Wolfe WG; Iglehart JD; Marks JR
    Cancer Res; 1995 Jan; 55(1):51-6. PubMed ID: 7805040
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Nuclear p53 overexpression is an independent prognostic parameter in node-negative non-small cell lung carcinoma.
    Dalquen P; Sauter G; Torhorst J; Schultheiss E; Jordan P; Lehmann S; Solèr M; Stulz P; Mihatsch MJ; Gudat F
    J Pathol; 1996 Jan; 178(1):53-8. PubMed ID: 8778317
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Accumulation of p53 protein correlates with a poor prognosis in human lung cancer.
    Quinlan DC; Davidson AG; Summers CL; Warden HE; Doshi HM
    Cancer Res; 1992 Sep; 52(17):4828-31. PubMed ID: 1324796
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Relationship of p53 overexpression and up-regulation of proliferating cell nuclear antigen with the clinical course of non-small cell lung cancer.
    Ebina M; Steinberg SM; Mulshine JL; Linnoila RI
    Cancer Res; 1994 May; 54(9):2496-503. PubMed ID: 7909277
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Autologous tumor killing activity as a prognostic factor in primary resected nonsmall cell carcinoma of the lung.
    Fujisawa T; Yamaguchi Y
    Cancer; 1997 Feb; 79(3):474-81. PubMed ID: 9028357
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 15.